EPAS1 and pancreatic neuroendocrine tumor: This study uncovers a previously unrecognized hypoxic-immune axis in pancreatic neuroendocrine tumors (PNETs), wherein HIF isoform imbalance (HIF-1α/β up regulation, HIF-2α down regulation) drives metastatic dissemination through immune suppression and metabolic rewiring.